Nutrition and Vitamin Partnering 2009-2014

  • April 2014
  • -
  • Currentpartnering
  • -
  • 250 pages

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service.

Nutrition & Vitamins Partnering 2009-2014 provides understanding and access to the nutrition & vitamins partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of nutrition & vitamins partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors nutrition & vitamins technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 220 links to online copies of actual liver disease deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of nutrition & vitamins partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in nutrition & vitamins partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.

Chapter 3 provides an overview of the leading nutrition & vitamins deals since 2009. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive directory of nutrition & vitamins partnering deals signed and announced since 2009. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the
research, development and commercialization of nutrition & vitamins technologies and products.

Report scope

Nutrition & Vitamins Partnering 2009-2014 is intended to provide the reader with an in-depth understanding and access to nutrition & vitamins trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

Trends in nutrition & vitamins dealmaking in the biopharma industry since 2009
Access to summary headline, upfront, milestone and royalty data
The leading nutrition & vitamins deals by value since 2009


In Nutrition & Vitamins Partnering 2009-2014, the available deals are listed by:

Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Nutrition & Vitamins Partnering 2009-2014 provides the reader with the following key benefits:

In-depth understanding of nutrition & vitamins deal trends since 2009
Access to summary headline, upfront, milestone and royalty data
Comprehensive access to over 220 actual nutrition & vitamins deals entered into by the world’s biopharma companies since 2009
Insight into key deal terms included in contracts, where disclosed
Understand the key deal terms companies have agreed in deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in nutrition & vitamins partnering

2.1. Introduction
2.2. Nutrition & vitamins partnering over the years
2.3. Bigpharma nutrition & vitamins dealmaking activity
2.4. Nutrition & vitamins partnering by deal type
2.5. Nutrition & vitamins partnering industry sector
2.6. Nutrition & vitamins partnering by stage of development
2.7. Nutrition & vitamins partnering by technology type
2.8. Disclosed financial deal terms for nutrition & vitamins partnering
2.8.1 Nutrition & vitamins headline values
2.8.2 Nutrition & vitamins upfront payments
2.8.3 Nutrition & vitamins milestone payments
2.8.4 Nutrition & vitamins royalty rates
Chapter 3 – Leading nutrition & vitamins deals

3.1. Introduction
3.2. Top nutrition & vitamins deals by value
3.3. Top nutrition & vitamins deals involving bigpharma
Chapter 4 – Dealmaking directory

4.1. Introduction
4.2. Company A-Z
4.3. By deal type
Asset purchase
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Contract service
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Manufacturing
Marketing
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Termination
4.4. By industry sector
Academic
Bigpharma
Biotech
Drug delivery
Medical device
Diagnostic
Generic pharma
Government
Non-profit
Pharmaceutical
Research tools
Services
Specialty pharma
4.5. By stage of development
Discovery
Pre-clinical
Phase I
Phase II
Phase III
Registration
Marketed
4.6. By technology type
Analysis
Animal models
Assays
Bioinformatics
Biological compounds
Biomarkers
Biomaterials
Cell culture
Cell therapy
Clinical testing
Diagnostic - companion
Devices
Diagnostics
Discovery tools
DNA probes
Drug delivery
Enabling technology
Epigenetics
Equipment
Facilities
Gene therapy
Genomics
Imaging
Industrial chemicals
In vitro models
Monoclonal antibodies
Nanotechnology
Oligonucleotide
Peptides
Personalised medicine
Processes
Proteomics
Radio/Chemo-therapy
Recombinant DNA
Research services
Research supplies
RNA therapeutics
Screening
Small molecules
Stem cells
Vaccines
Chapter 5 – Partnering resource center

5.1. Online partnering
5.2. Partnering events
5.3. Further reading on dealmaking
Appendices

Appendix 1 – Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent titles from CurrentPartnering
Order Form – Reports
Table of figures

Figure 1: Nutrition & vitamins partnering since 2009
Figure 2: Bigpharma – top 50 – nutrition & vitamins deals 2009 to 2011
Figure 3: Bigpharma nutrition & vitamins deal frequency – 2009 to 2011
Figure 4: Nutrition & vitamins partnering by deal type since 2009
Figure 5: Nutrition & vitamins partnering by industry sector since 2009
Figure 6: Nutrition & vitamins partnering by stage of development since 2009
Figure 7: Nutrition & vitamins partnering by technology type since 2009
Figure 8: Nutrition & vitamins deals with a headline value
Figure 9: Nutrition & vitamins deals with upfront payment values
Figure 10: Nutrition & vitamins deals with milestone payments
Figure 11: Nutrition & vitamins deals with royalty rates, %
Figure 12: Top nutrition & vitamins deals by value since 2009
Figure 13: Top nutrition & vitamins deals signed by bigpharma value since 2009
Figure 14: Online partnering resources
Figure 15: Forthcoming partnering events
Figure 16: Deal type definitions
$1,695: single-user
$2,595: multi-user
$5,095: single site license
$8,475: global site license
An annual subscription to quarterly updates can be purchased for a small additional fee; ensuring you are kept up-to-date with the very latest nutrition & vitamins partnering deals. Quarterly updates available from $847.50.

A full explanation of license type definitions can be found here.

An additional $500 per copy will be added for full print and CD-ROM requests.

Table Of Contents

Executive Summary




Chapter 1 - Introduction




Chapter 2 - Trends in nutrition and vitamins partnering



•2.1. Introduction
•2.2. Nutrition and vitamins partnering over the years
•2.3. Bigpharma nutrition and vitamins dealmaking activity
•2.4. Nutrition and vitamins partnering by deal type
•2.5. Nutrition and vitamins partnering industry sector
•2.6. Nutrition and vitamins partnering by stage of development
•2.7. Nutrition and vitamins partnering by technology type
•2.8. Disclosed financial deal terms for nutrition and vitamins partnering
•2.8.1 Nutrition and vitamins headline values
•2.8.2 Nutrition and vitamins upfront payments
•2.8.3 Nutrition and vitamins milestone payments
•2.8.4 Nutrition and vitamins royalty rates



Chapter 3 - Leading nutrition and vitamins deals



•3.1. Introduction
•3.2. Top nutrition and vitamins deals by value
•3.3. Top nutrition and vitamins deals involving bigpharma



Chapter 4 - Dealmaking directory



•4.1. Introduction
•4.2. Company A-Z
•4.3. By deal type
•Asset purchase
•Bigpharma outlicensing
•Co-development
•Collaborative RandD
•Co-market
•Contract service
•Co-promotion
•CRADA
•Cross-licensing
•Development
•Distribution
•Equity purchase
•Evaluation
•Grant
•Joint venture
•Licensing
•Manufacturing
•Marketing
•Option
•Promotion
•Research
•Settlement
•Spin out
•Sub-license
•Supply
•Termination
•4.4. By industry sector
•Academic
•Bigpharma
•Biotech
•Drug delivery
•Medical device
•Diagnostic
•Generic pharma
•Government
•Non-profit
•Pharmaceutical
•Research tools
•Services
•Specialty pharma
•4.5. By stage of development
•Discovery
•Pre-clinical
•Phase I
•Phase II
•Phase III
•Registration
•Marketed
•4.6. By technology type
•Analysis
•Animal models
•Assays
•Bioinformatics
•Biological compounds
•Biomarkers
•Biomaterials
•Cell culture
•Cell therapy
•Clinical testing
•Diagnostic - companion
•Devices
•Diagnostics
•Discovery tools
•DNA probes
•Drug delivery
•Enabling technology
•Epigenetics
•Equipment
•Facilities
•Gene therapy
•Genomics
•Imaging
•Industrial chemicals
•In vitro models
•Monoclonal antibodies
•Nanotechnology
•Oligonucleotide
•Peptides
•Personalised medicine
•Processes
•Proteomics
•Radio/Chemo-therapy
•Recombinant DNA
•Research services
•Research supplies
•RNA therapeutics
•Screening
•Small molecules
•Stem cells
•Vaccines



Chapter 5 - Partnering resource center



•5.1. Online partnering
•5.2. Partnering events
•5.3. Further reading on dealmaking



Appendices



•Appendix 1 - Deal type definitions
•About Wildwood Ventures
•Current Partnering
•Current Agreements
•Recent titles from CurrentPartnering
•Order Form - Reports




Table of figures




•Figure 1: Nutrition and vitamins partnering since 2009
•Figure 2: Bigpharma - top 50 - nutrition and vitamins deals 2009 to 2014
•Figure 3: Bigpharma nutrition and vitamins deal frequency - 2009 to 2014
•Figure 4: Nutrition and vitamins partnering by deal type since 2009
•Figure 5: Nutrition and vitamins partnering by industry sector since 2009
•Figure 6: Nutrition and vitamins partnering by stage of development since 2009
•Figure 7: Nutrition and vitamins partnering by technology type since 2009
•Figure 8: Nutrition and vitamins deals with a headline value
•Figure 9: Nutrition and vitamins deals with upfront payment values
•Figure 10: Nutrition and vitamins deals with milestone payments
•Figure 11: Nutrition and vitamins deals with royalty rates, %
•Figure 12: Top nutrition and vitamins deals by value since 2009
•Figure 13: Top nutrition and vitamins deals signed by bigpharma value since 2009
•Figure 14: Online partnering resources
•Figure 15: Forthcoming partnering events
•Figure 16: Deal type definitions

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Extruded Snacks Market by Type (Potato, Corn, Rice, Tapioca, Mixed Grain, and Others) & by Geography - Global Trends and Forecasts to 2019

Extruded Snacks Market by Type (Potato, Corn, Rice, Tapioca, Mixed Grain, and Others) & by Geography - Global Trends and Forecasts to 2019

  • $ 4 650
  • Industry report
  • July 2014
  • by MarketsandMarkets

Report Description Extruded snacks are obtained through the extrusion technology, either directly or through the processing of snack pellets. The advanced technologies offer advantages such as innovative ...

Global Database of the Top 1000 Health Food Supplement Stores - Company Names, Financial Performance, Key Executives, and Contact Details

Global Database of the Top 1000 Health Food Supplement Stores - Company Names, Financial Performance, Key Executives, and Contact Details

  • $ 1 317
  • Industry report
  • August 2014
  • by Global Research & Data Services

This company database offers valuable information on top 1000 health food supplement stores in the world which makes the database an invaluable resource for industry executives, marketing, sales and product ...

Global Franchise Group, LLC: Foodservice - Company Profile and SWOT Report

Global Franchise Group, LLC: Foodservice - Company Profile and SWOT Report

  • $ 125
  • Industry report
  • July 2014
  • by Canadean Ltd

Synopsis Canadean's "Global Franchise Group, LLC: Foodservice - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company ...

World Market Organic Food

April 2014 $ 350

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.